JAMES MOORE: Open Payments
NPI 1417107905 · BOYD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$108 in 5 payments from 4 companies in 2025. Trend: 2023 $1,102 · 2024 $1,345 · 2025 $108
Food & beverage: $108
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: DUPIXENT, TRELEGY ELLIPTA, EBGLYSS, TEZSPIRE.
Industry payments across TX — which companies pay providers there.
